Chenfang Dong, Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Oncology | Breast Cancer | Tumor Metabolism | Tumor Emt | Tumor Stem Cells | Epigenetic Modifications | Protein Lactylation | Cancer Research | Metabolic Reprogramming | Emt Induction |
Jingjing Wu, Associate Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Tumor | Molecular Mechanisms | Cancer Research | Pathophysiology | Genetics | Oncology | Cell Biology | Biomarkers | Therapeutics | Disease Mechanisms |
Kai Wang, Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Lung Cancer | Targeted Therapy | Immunotherapy | Efficacy Mechanisms | Microenvironment | Regulation | Anti-Cancer Drugs | Drug Development | Cancer Research | Oncology |
Zhangfa Song, Chief Physician, Doctoral Supervisor, Deputy Director
Zhejiang University, Medical
Area of Focus
Colorectal Cancer | Microenvironment | Metastasis | Drug Resistance | Minimally Invasive Surgery | Diagnosis | Treatment | Cancer Research | Oncology | Clinical Research |
Chao Ni, Associate Chief Physician, Associate Professor, Researcher, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Breast Cancer | Immunomicroenvironment | Drug Resistance | Precision Treatment | Endocrine Resistance | Immune Regulation | Oncology | Cancer Research | Tumor Microenvironment | Breast Surgery |
Zhongjie Li, Lecturer
Zhejiang University, Medical
Area of Focus
Cellular Biology | Molecular Biology | Carcinogenesis | Chemical Carcinogens | Cancer Research | Cell Signaling | Molecular Mechanisms | Oncology | Biochemistry | Toxicology |
Yang Xia, Associate Chief Physician, Associate Professor, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Lung Cancer | Immunotherapy | Targeted Therapy | Medical Ai | Radiomics | Oncology | Cancer Research | Biomarkers | Precision Medicine | Clinical Trials |
Jian Wang, Associate Chief Physician, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Single-Cell Sequencing | Multi-Omics | Colorectal Cancer | Molecular Mechanisms | Immune Microenvironment | Therapeutic Resistance | Cancer Development | Cancer Occurrence | Colorectal Tumor | Cancer Research |
Rongzhen Xu, Researcher, Doctoral Supervisor
Zhejiang University, Medical
Area of Focus
Internal Medicine | Hematology | Hematologic Tumors | Etiology | Pathogenesis | Molecular Targeted Drugs | Anti-Tumor | Drug Development | Cancer Research | Oncology |
Wenxian Hu, Associate Chief Physician, Master's Supervisor
Zhejiang University, Medical
Area of Focus
Breast Cancer | Radiotherapy | Chemotherapy | Resistance | Klf4 | Lin28 | Thyroid Cancer | Sentinel Lymph Node | Oncology | Cancer Research |